Navigation Menu

Clinical Trial External Search


Children (age < 18 years)
Adults (age >= 18 years)

Researcher Profile

Researcher Display

Chandrika Behura, MD

Chandrika Behura, MD

Associate Professor, Department of Pediatrics
Division of Hematology and Oncology
Penn State Neuroscience Institute
Scientific Program:Experimental Therapeutics
Disease Teams:
Cancer Institute, Pediatric Cancer Team
CXG40@psu.edu

Clinical Trials

A Phase 3 Randomized Controlled Trial Comparing Open vs Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
Phase II Trial of Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma BCC022
ACCL1931: A Randomized Trial of Levocarnitine Prophylaxis to Prevent Asparaginase-Associated Hepatotoxicity in Adolescents and Young Adults Receiving Acute Lymphoblastic Leukemia Therapy
BCC021 Phase I/II study of Silmitasertib (CX-4945) in combination with chemotherapy in children and young adults with relapsed refractory solid tumors
Pediatric Acute Leukemia (PedAL) Screening Trial Developing New Therapies for Relapsed Leukemias
ARAR2221 A Phase 2 Study Using Chemoimmunotherapy with Gemcitabine, Cisplatin and Nivolumab in Newly Diagnosed Nasopharyngeal Carcinoma (NPC)
A Prospective Phase 3 Study of Patients with Newly Diagnosed Very Low-risk and Low-risk Fusion Negative Rhabdomyosarcoma
A Dose Escalation Study Using Difluoromethylornithine (DFMO) and AMXT-1501 followed by a Randomized Controlled Trial of DFMO with or without AMXT-1501 for Neuroblastoma, CNS Tumors, and Sarcomas
AHOD2131 A Randomized Phase 3 Interim Response Adapted Trial Comparing Standard Therapy with Immuno-oncology Therapy for Children and Adults with Newly Diagnosed Stage I and II Classic Hodgkin Lymphoma

Recent Publications

2025

Rajaiah, R, Daniyal, M, Shanmugam, MP, Valensi, H, Duke, K, Mercer, K, Klink, M, Lanza, M, Uzun, Y, Huang, S, Dovat, S & Behura, CG 2025, 'CK2α Deletion in the Hematopoietic Compartment Shows a Mild Alteration in Terminally Differentiated Cells and the Expansion of Stem Cells', Cells, vol. 14, no. 13, 963. https://doi.org/10.3390/cells14130963

2024

Zhang, L, Muscat, JE, Chinchilli, VM & Behura, CG 2024, 'Trends in Cancer Incidence and Mortality in US Adolescents and Young Adults, 2016–2021', Cancers, vol. 16, no. 18, 3153. https://doi.org/10.3390/cancers16183153

2023

Bogush, D, Schramm, J, Ding, Y, He, B, Singh, C, Sharma, A, Tukaramrao, DB, Iyer, S, Desai, D, Nalesnik, G, Hengst, J, Bhalodia, R, Gowda, C & Dovat, S 2023, 'Signaling pathways and regulation of gene expression in hematopoietic cells', Advances in Biological Regulation, vol. 88, 100942. https://doi.org/10.1016/j.jbior.2022.100942

2022

Wills, C, Mercer, K, Malysz, J, Galvis, LR & Gowda, C 2022, 'Chronic Generalized Lymphadenopathy in a Child—Progressive Transformation of Germinal Centers (PTGC)', Children, vol. 9, no. 2, 214. https://doi.org/10.3390/children9020214
Dovat, S, Gowda, C, Mailman, RB, Parent, LJ & Huang, X 2022, 'Clinician-Scientist Faculty Mentoring Program (FAME) – A New Inclusive Training Model at Penn State Increases Scholarly Productivity and Extramural Grant Funding', Advances in Medical Education and Practice, vol. 13, pp. 1039-1050. https://doi.org/10.2147/AMEP.S365953
Gowda, C, Purandare, A, Mercer, K, Duke, K & Dovat, S 2022, 'Novel Casein Kinase II (CK2) inhibitor BMS-135 shows significant in vivo anti-leukemia effect', European Journal of Cancer, vol. 174, pp. S29. https://doi.org/10.1016/S0959-8049(22)00879-6